Innovative Eyewear filings document a Nasdaq-listed smart eyewear issuer with common stock under LUCY and warrants under LUCYW. Recent Form 8-K reports cover results of operations, preliminary financial information, operational highlights, executive title and principal financial officer changes, and annual-meeting matters.
The company's regulatory disclosures also record stockholder voting outcomes, director elections, auditor ratification matters, quorum and adjournment mechanics, exhibit filings and Inline XBRL cover-page data. These filings frame the public-company record around governance, capital structure and event-driven disclosures for its smart eyewear business.
Innovative Eyewear Inc (symbol LUCY) is the issuer for a notice of proposed sale of securities filed on behalf of officer David Eric Cohen under Rule 144. The notice covers a planned sale of up to 18,200 shares of common stock, expected on or about 08/19/2026, through Raymond James & Associates, Inc. The shares are described as originating from an RSU Grant by the issuer, with cash as the form of payment. The filing also reports that Cohen sold 1,860 shares of common stock on 07/06/2026 during the prior three months.
Innovative Eyewear Inc (LUCY) had a notice filed under Rule 144 for a planned sale of its common stock by officer Konrad Dabrowski. Up to 20,900 shares may be sold through Raymond James & Associates, Inc. on Nasdaq, with an aggregate market value of $14,839.00. The shares relate to an RSU Grant, and total common shares outstanding are listed as 6,403,728, a baseline figure rather than the amount being sold.
Innovative Eyewear Inc (LUCY) received a Rule 144 notice indicating that officer Harrison R. Gross plans to resell up to 24,600 shares of common stock. The shares relate to an RSU grant from the issuer and are expected to be sold for cash through Raymond James & Associates, Inc., with an approximate sale date of 08/19/2026.
Innovative Eyewear Inc (LUCY) has a notice of proposed sale of common stock filed on behalf of officer Joaquin Abondano under Rule 144. The notice lists a potential sale of 4,389 common shares through Raymond James & Associates, Inc., with an aggregate market value of $3,120.58 and 6,403,728 shares of common stock outstanding. The securities are tied to a 14,800-share RSU grant, with cash as the form of payment. Melissa Fisher signed as a duly authorized representative of Raymond James & Associates, Inc., acting as attorney-in-fact for Joaquin Abondano.
Innovative Eyewear Inc (symbol LUCY) has a notice filed under Rule 144 indicating a proposed sale of up to 18,200 shares of its common stock for the account of officer David Eric Cohen. Raymond James & Associates, Inc. is listed as the broker for these shares.
The shares to be sold arise from an RSU Grant from the issuer, with the form indicating cash as the payment type. The notice also lists a prior sale by David Cohen of 1,860 common shares during the past three months.
Innovative Eyewear Inc (LUCY) is the issuer for a notice of proposed sale of securities under Rule 144 filed for officer Gayle Oswald. The notice covers up to 16,233 shares of common stock to be sold through Raymond James & Associates, Inc., arising from an RSU grant. Shares outstanding were 6,403,728 common shares as of 08/19/2026; this is a baseline figure, not the amount being sold.
Innovative Eyewear, Inc. reported strong top-line growth but continued losses for the quarter and six months ended June 30, 2026. Quarterly revenue was $1,010,519, up sharply from 2025 levels, driven mainly by Lucyd Armor smart safety glasses and Reebok-branded smartglasses across Lucyd.co, Amazon, and growing wholesale channels. Gross margin improved to 24%, compared with a small gross deficit a year earlier, as the company mitigated tariff impacts and benefited from better sourcing and scale.
Despite this, the company posted a quarterly net loss of $1,670,818 and a six‑month net loss of $3,980,186, reflecting ongoing spending on general and administrative, marketing, and product development. Cash and cash equivalents were $2.5 million, with total liquidity of about $3.7 million including U.S. Treasury bills, and working capital of roughly $6.2 million. Management expects liquidity to fund operations for at least 12 months, supplemented by a July 2026 warrant inducement that raised about $3.0 million before fees and an undrawn related‑party credit facility. However, disclosure controls and procedures were deemed ineffective due to material weaknesses in internal control over financial reporting.
Innovative Eyewear, Inc. is registering the resale of up to 6,766,673 shares of common stock, all issuable upon exercise of outstanding warrants held by selling stockholders. This includes 6,601,632 shares underlying Series J Investor Warrants exercisable at $1.10 per share and 165,041 shares underlying placement agent warrants exercisable at $1.6875 per share. The company will not receive proceeds from stockholder resales, but may receive cash if these warrants are exercised for cash, to be used for general corporate and working capital purposes.
The company develops and sells smart eyewear and related software, including Lucyd Lyte, Nautica, Eddie Bauer, Reebok and Lucyd Armor-branded products, and offers the Lucyd app with AI and communication features. As of July 22, 2026, 8,606,272 shares of common stock were outstanding; assuming full exercise of all Warrants, 15,372,945 shares would be outstanding. The common stock trades on Nasdaq under “LUCY,” with a last reported price of $0.68 per share on July 22, 2026. Innovative Eyewear qualifies as an emerging growth company and notes that investing in its securities involves a high degree of risk.
Innovative Eyewear, Inc. entered an inducement agreement with a warrant holder to immediately exercise 2,200,544 existing warrants at a reduced price of $1.35 per share, generating approximately $3.0 million in gross proceeds. In return, the company is issuing new unregistered Series J warrants to purchase up to 6,601,632 shares of common stock at an exercise price of $1.10 per share, exercisable immediately for 24 months after a future resale registration becomes effective. The company plans to use net proceeds for working capital and general corporate purposes, has engaged H.C. Wainwright & Co. as exclusive placement agent with cash fees and expense reimbursements, and will also issue placement agent warrants to buy 165,041 shares at $1.6875 per share.